Labcorp (LH) Financials: Revenue & Earnings
$29.77B
Market Cap
29.38
P/E
18.88
Forward P/E
42
Score
AI Analysis
SnapshotLabcorp Holdings doesn’t screen as a clean setup today — Stocklytics 42/100 leaves more to prove. Under the hood: P/E 30.0, rich vs its own history, plus revenue compounding ~6% annually over recent years.
Price History
Price: —
Fair value: —
—
P/E (TTM): —
Net Income (TTM): —
Score: —
—
Score Breakdown
Market percentile scores loading…
Value
Growth
Quality
Financial Summary
Labcorp Holdings Inc. (LH) last printed $366.57. Equity value is $29.77B. Trailing earnings multiple 29.38. The revenue row is reported history. Targets and ratings are on the forecast page.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| $9.64B | $10.44B | $11.33B | $11.55B | $13.98B | $13.14B | $11.86B | $12.16B | $13.01B | $13.95B |
About
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.